Back to
MOORE CAPITAL MANAGEMENT, LP
IOVA
Showing 0 of 11 quarters
Position history for
MOORE CAPITAL MANAGEMENT, LP's holdings in IOVANCE BIOTHERAPEUTICS INC
No. Moore Capital Management exited its IOVA (Iovance Biotherapeutics) position in Q2 2021. Its Q1 2021 13F listed 25,000 shares worth $792,000. Moore Capital Management already held IOVA in its Q4 2018 13F, the earliest on record, and held it in 10 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.